Dr. Aldo Pourchet, Omios Biologics
RealTime-Glo™ Extracellular ATP Assay
Despite the long history, oncolytic viruses have only recently gained momentum in the scientific community. Dr. Aldo Pourchet, CSO and co-founder of Omios Biologics—a biotech startup in the San Francisco Bay area—is determined to harness the power of oncolytic viruses to develop a new generation of cancer immunotherapy.
![](https://scv10mr-cdnpre-p-cus-00.azureedge.net/-/media/images/resources/articles-and-publications/pubhub/customer-spotlights/aldo-pourchet-video-poster-800x450.jpg?rev=f90e68a14af849b6bf789c7197d84980&sc_lang=en)
Learn More
How to Measure Immunogenic Cell Death in Real Time
RealTime-Glo™ Extracellular ATP Assay